Mid-regional pro-atrial natriuretic peptide independently predicts short-term mortality in COVID-19.

Christoph C KaufmannAmro AhmedMona KassemMatthias K FreynhoferBernhard JägerGabriele AicherSusanne Equiluz-BruckAlexander O SpielGeorg-Christian FunkMichael GschwantlerPeter FaschingJohann WojtaKurt Huber

Published in: European journal of clinical investigation (2021)

Higher levels of MR-proANP at admission are associated with disease severity of COVID-19 and act as a powerful and independent prognostic marker of 28-day mortality.

Keyphrases

coronavirus disease
sars cov
cardiovascular events
emergency department
atrial fibrillation
magnetic resonance
respiratory syndrome coronavirus
left atrial
heart failure
mitral valve